Fermi - no, similar to Exelon & Susquehanna responses
Benjy Bertossi Fermi2 - RP Supervisor 734-586-1072 or 4935 [email protected] -----"Harris, Willie O:(GenCo-Nuc)" <[email protected]> wrote: ----- To: "Barnhill, Cynthia Speed" <[email protected]>, "'[email protected]'" <[email protected]> From: "Harris, Willie O:(GenCo-Nuc)" <[email protected]> Date: 05/18/2016 13:31 Cc: "LaFrate, Patrick Joseph" <[email protected]> Subject: [powernet] RE: Quick Benchmark on ED only entries into RCA See below Willie Harris, CHP RRPT Director, Radiation Protection 200 Exelon Way Kennett Square, PA 19348 Office Phone: 610.765.5350 Cell: 484-885-0578 [email protected] From: Barnhill, Cynthia Speed [mailto:[email protected]] Sent: Wednesday, May 18, 2016 1:05 PM To: '[email protected]' Cc: Barnhill, Cynthia Speed; LaFrate, Patrick Joseph Subject: [EXTERNAL] [powernet] Quick Benchmark on ED only entries into RCA I'm performing a quick benchmark to determine efficiencies gained and/or cost savings by allowing entry into the RCA with only an electronic dosimeter. 1. Does your utility allow entry into the RCA with only an electronic dosimeter under certain conditions or for certain types of workers (i.e., no TLD, OSLD)? Yes 2. If so, what are the plant conditions/limitations and or types of workers (i.e., vendors, visitors)? Escorted Visitors , typical exposure of 0, 3. Is the entry recorded into the normal access control system or other means such as manual entry? Manual Log 4. What are the pros and cons that your utility has seen with this practice? Cost savings associated with the visitor process 5. What, if any, regulator or assessor feedback have you received on this practice? No feedback Any additional information you may have on this subject is welcome. Thank you. Cindy Barnhill | Sr. Scientist | Fleet Scientific Services | Dosimetry | Duke Energy 13339 Hagers Ferry Road | Mail Stop MG03A2 | Huntersville, NC 28078 | 980-875-5313 office | 704-363-9417 cell This Email message and any attachment may contain information that is proprietary, legally privileged, confidential and/or subject to copyright belonging to Exelon Corporation or its affiliates ("Exelon"). This Email is intended solely for the use of the person(s) to which it is addressed. If you are not an intended recipient, or the employee or agent responsible for delivery of this Email to the intended recipient(s), you are hereby notified that any dissemination, distribution or copying of this Email is strictly prohibited. If you have received this message in error, please immediately notify the sender and permanently delete this Email and any copies. Exelon policies expressly prohibit employees from making defamatory or offensive statements and infringing any copyright or any other legal right by Email communication. Exelon will not accept any liability in respect of such communications. -EXCIP
